GDNF and NT-4 protect midbrain dopaminergic neurons from toxic damage by iron and nitric oxide

Experimental Neurology

Volumn 163, Issue 1, 2000, Pages 55-62

  Lingor, Paul ^a   Unsicker, Klaus ^a   Krieglstein, Kerstin ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Cell culture; Dopaminergic cells; Free radicals; Neurotrophic factors; Oxidative stress; Parkinson's disease

Indexed keywords

FERRIC CHLORIDE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; IRON; LACTATE DEHYDROGENASE; NEUROPROTECTIVE AGENT; NEUROTROPHIC FACTOR; NEUROTROPHIN 4; NITROPRUSSIDE SODIUM;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; EMBRYO; IRON OVERLOAD; MESENCEPHALON; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 0034024177     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7339     Document Type: Article

References (40)

1. Banati R. B., Gehrmann J., Schubert P., Kreutzberg G. W. Cytotoxicity of Microglia. Glia. 7:1993;111-118.
2. Choi-Lundberg D. L., Lin Q., Chang Y. N., Chiang Y. L., Hay C. M., Mohajeri H., Davidson B. L., Bohn M. C. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science. 275:1997;838-841.
3. Clarkson E. D., Zawada W. M., Freed C. R. GDNF reduces apoptosis in dopaminergic neurons in vitro. NeuroReport. 7:1995;145-149.
4. Damier P., Hirsch E. C., Zhang P., Agid Y., Javoy-Agid F. Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience. 52:1993;1-6.
5. Dexter D. T, Carter C. J., Wells F. R. Lipid peroxidation as a cause of nigral cell death in Parkinson's disease. Lancet. 2:1986;639-640.
6. Dexter D. T., Wells F. R., Lees A. J., Agid F., Agid Y., Jenner P., Marsden C. D. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52:1989;1830-1836.
7. Ebadi M., Srinivasan S. K., Baxi M. D. Oxidative stress and antioxidant therapy in Parkinson's disease. Prog. Neurobiol. 48:1996;1-19.
8. Engele J., Bohn M. C. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J. Neurosci. 11:1991;3070-3078.
9. Engele J., Schilling K. Growth factor-induced c-fos expression defines distinct subsets of midbrain dopaminergic neurons. Neuroscience. 73:1996;397-406.
10. Fahn S., Cohen G. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it. Ann. Neurol. 32:1992;804-812.
11. Götz M. E., Kunig G., Riederer P., Youdim M. B. Oxidative stress: Free radical production in neural degeneration. Pharmacol. Ther. 63:1994;37-122.
12. Gorell J. M., Johnson C. C., Rybicki B. A., Peterson E. L., Kortsha G. X., Brown G. G., Richardson R. J. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology. 48:1997;650-658.
13. Green S. J., Nacy C. A., Meltzer M. S. Cytokine-induced synthesis of nitogen oxides in macrophages: A protective host response to Leishmania and other intracellular pathogens. J. Leukocyte Biol. 50:1991;93-103.
14. Hantraye P., Brouillet E., Ferrante R., Palfi S., Dolan R., Matthews R. T., Beal M. F. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nature Med. 2:1996;1017-1021.
15. Hirsch C. E., Hunot S., Faucheux B., Agid Y., Mizuno Y., Mochizuki H., Tatton W. G., Tatton N., Olanow W. C. Dopaminergic neurons degenerate by apoptosis in Parkinson's disease. Mov. Disord. 14:1999;383-384.
16. Hyman C., Hofer M., Barde Y. A., Juhasz M., Yancopoulos G. D., Squinto S. P., Lindsay R. M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 350:1991;230-232.
17. Hyman C., Juhasz M., Jackson C., Wright P., Ip N. Y., Lindsay R. M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14:1994;335-347.
18. Hynes M. A., Poulsen K., Armanini M., Berkemeier L., Phillips H., Rosenthal A. Neurotrophin-4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures. J. Neurosci. Res. 37:1994;144-154.
19. Jenner P. Oxidative stress as a cause of Parkinson's disease. Acta Neurol. Scand. 84:1991;6-15.
20. Kienzl E., Jellinger K., Stachelberger H., Linert W. Iron as catalyst for oxydative stress in the pathogenesis of Parkonson's disease? Life Sci. 65:1999;1973-1976.
21. Knüsel B., Michel P. P., Schwaber J. S., Hefti F. Selective and nonselective stimulation of cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J. Neurosci. 10:1990;558-570.
22. Kopin I. J. MPTP: An industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease. Environ. Health Perspect. 75:1987;45-51.
23. + toxicity. EMBO J. 14:1995;736-742.
24. Krieglstein K., Suter-Crazzolara C., Hotten G., Pohl J., Unsicker K. Trophic and protective effects of growth differentiation factor 5, a member of the transforming growth factor beta superfamily, on midbrain dopaminergic neurons. J. Neurosci. Res. 42:1995;724-732.
25. Lin L. H., Doherty D. H., Lile J. D., Bektesh S., Collins F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1332.
26. Mergler D., Huel G., Bowler R., Iregren A., Belanger S., Baldwin M., Tardif R., Smargiassi A., Artin L. Nervous system dysfunction among workers with long-term exposure to manganese. Environ. Res. 64:1994;151-180.
27. Michel P. P, Vyas S., Agid Y. Toxic effects of iron for cultured mesencephalic dopaminergic neurons derived from rat embryonic brains. J. Neurochem. 59:1992;118-127.
28. Nicklas W. J., Youngster S. K., Kindt M. V., Heikilla R. E. MPTP, MPP+ and mitochondrial function. Life Sci. 40:1987;721-729.
29. Otto D., Unsicker K. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J. Neurosci. 10:1990;1912-1821.
30. Otto D., Unsicker K. FGF-2 in the MPTP model of Parkinson's disease: Effects on astroglial cells. Glia. 11:1994;47-56.
31. Pochon N. A., Menoud A., Tseng J. L., Zurn A. D., Aebischer P. Neuronal GDNF expression in the adult rat nervous system identified by in situ hybridization. Eur. J. Neurosci. 9:1997;463-471.
32. Ruberg M., Brugg B., Prigent A., Hirsch E., Brice A., Agid Y. Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis? J. Neurochem. 68:1997;2098-2110.
33. Ruberg M., France-Lanord V., Brugg B., Lambeng N., Michel P. P., Hunot S., Damier P., Faucheux B., Hirsch E. C., Agid Y. Neuronal death due to apoptosis in Parkinson's disease. Rev. Neurol. 153:1997;499-508.
34. Sauer H., Rosenblad C., Bjorklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sci. USA. 92:1995;8935-8939.
35. Thery C., Chamak B., Mallat M. Cytotoxic effect of brain macrophages on developing neurons. Eur. J. Neurosci. 3:1991;1155-1164.
36. Tomac A., Lindqvist E., Lin L. F., Ogren S. O., Young D., Hoffer B. J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
37. Trupp M., Belluardo N., Funakoshi H., Ibanez C. F. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. J. Neurosci. 17:1997;3554-3567.
38. Unsicker K. Growth factors in Parkinson's disease. Prog. Growth Factor Res. 5:1994;73-87.
39. Unsicker K., Suter-Crazzolara C., Krieglstein K. Growth factor function in the development and maintenance of midbrain dopaminergic neurons: Concepts, facts and prospects for TGF-beta. Ciba Found. Symp. 196:1996;70-80.
40. Unsicker K., Suter-Crazzolara C., Krieglstein K. Neurotrophic roles of GDNF and related factors. Handbook Exp. Pharmacol. 134:1999;189-224.